Patent · US Expired

Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis

US7262271B2 · kind B2 · utility

13Cited by

7References

14Claims

0Family size

Assignees

CSL LIMITED · AU
The University of Melbourne · AU

Inventors

Eric Charles Reynolds · Melbourne, AU
Neil Martin O'Brien-Simpson · Brunswick, AU
Nada Slakeski · Melbourne, AU

Key dates

Filing date	Mar 12, 2003
Grant date	Aug 28, 2007
Priority date	—
Expiry date	Dec 30, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6037
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an oral composition and an immunogenic composition for the suppression of the pathogenic effects of the intra-oral bacterium Porphyromonas gingivalis associated with periodontal disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.